Bipolar disorder and adiposity: a study using whole body dual energy X-ray absorptiometry scans
Lana J Williams, Julie A Pasco, Felice N Jacka, Margaret J Henry, Seetal Dodd, Geoffrey C Nicholson, Mark A Kotowicz, Michael Berk
Acta Neuropsychiatrica | WILEY-BLACKWELL | Published : 2011
Awarded by National Health and Medical Research Council of Australia
The study was funded by the National Health and Medical Research Council of Australia (251638) and supported by an unrestricted educational grant from Eli Lilly. The funding bodies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the paper for publication.Lana Williams, Felice Jacka, Julie Pasco and Seetal Dodd have received research support from an unrestricted educational grant from Eli Lilly. Margaret Henry, Mark Kotowicz and Geoffrey Nicholson have no conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript. Michael Berk has received Grant/Research Support from the Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. He has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth.